AHFS October 2025 Update

This update contains 8 new monographs, 34 revised monographs.

New monographs: Delgocitinib; Dordaviprone Hydrochloride; Linvoseltamab-gcpt; Measles, Mumps, and Rubella Virus Vaccine Live ; Porfimer Sodium; Sunvozertinib; Telmisartan, amlodipine, and indapamide; Zongertinib.

Revised monographs: ADAMTS13, Recombinant-krhn; Amlodipine; Atogepant; Atomoxetine Hydrochloride; Berdazimer Sodium; Cabotegravir; Cabotegravir and Rilpivirine; Cefuroxime; Concizumab-mtci; Delandistrogene Moxeparvovec-rokl; Encorafenib; Ensartinib Hydrochloride; Fedratinib Hydrochloride; Fingolimod Hydrochloride; Fitusiran; Imatinib Mesylate; Iptacopan Hydrochloride; Irbesartan; Isatuximab-irfc; Larotrectinib Sulfate; Lisinopril; Losartan Potassium; Mavacamten; Mecasermin; metFORMIN Hydrochloride; Methadone Hydrochloride; Methylphenidate; Nedosiran Sodium; Palonosetron Hydrochloride; Ranibizumab; Somapacitan-beco; Somatrogon-ghla; Somatropin; Vandetanib.